Hepatocyte transplantation (HcTx) is a promising approach for the treatment of metabolic diseases in newborns and children. The most common application route is the portal vein, which is difficult to access in the newborn. Transfemoral access to the splenic artery for HcTx has been evaluated in adults, with trials suggesting hepatocyte translocation from the spleen to the liver with a reduced risk for thromboembolic complications.
View Article and Find Full Text PDFObjective: After recent evaluations of the ALPPS registry, with perioperative results sobering in particular for central bile duct carcinomas, the initial euphoria for this procedure disappeared. It is thus desirable to modify the concept of reducing the invasiveness and high complication rate of the procedure.
Indications: Below we report a 72-year-old female patient with a gallbladder carcinoma locally infiltrating and metastatic to segments 4 b and 5.
Eur J Endocrinol
October 2018
Objective: Adrenal vein sampling (AVS) represents the current diagnostic standard for subtype differentiation in primary aldosteronism (PA). However, AVS has its drawbacks. It is invasive, expensive, requires an experienced interventional radiologist and comes with radiation exposure.
View Article and Find Full Text PDFBackground: Hepatic arterial infusion (HAI) of chemotherapy requires the implantation of a transcatheter application system which is traditionally performed by surgery. This procedure, but particularly the adjacent drug application via pump or port is often hampered by specific complications and device failure. Interventionally implanted port catheter systems (IIPCS) facilitate the commencement of HAI without need for laparatomy, and are associated with favorable complication rates.
View Article and Find Full Text PDF